• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bionor Pharma ASA

+ Add to Watchlist

BIONOR:SS

2.9300 NOK 0.0600 2.01%

As of 12:00:02 ET on 08/13/2014.

Snapshot for Bionor Pharma ASA (BIONOR)

Open: 2.9300 Day's Range: 2.9300 - 2.9300 Volume: 11
Previous Close: 2.9900 52wk Range: 2.4000 - 3.2800 1-Yr Rtn: -

Stock Chart for BIONOR

No chart data available.
  • BIONOR:SS 2.9300
  • 1D
  • 1M
  • 1Y
2.9900
Interactive BIONOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIONOR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -0.2800
Est. PEG Ratio -
Market Cap (M NOK) 661.67
Shares Outstanding (M) 225.83
30 Day Average Volume 1
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIONOR

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for BIONOR

Bionor Pharma ASA is a biotechnology company. The Company develops therapeutic peptide vaccines that stimulate cell-mediated immunity. Bionor Pharma targets diseases that include chronic infections such as HIV, Hepatitis C (HCV), Human Papilloma Virus (HPV) and Influenza.

Steen KroyerDeputy ChairmanAnker LundemosePresident/CEO
Synne H RoineChief Financial OfficerVidar Wendel-HansenChief Medical Officer
More Company Profile & Key Executives for BIONOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil